Ameritas Investment Partners
LENZ icon

Ameritas Investment Partners’s LENZ Therapeutics LENZ Stock Holding History

Ameritas Investment Partners’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.67K Hold
1,351
– – ﹤0.01% 3050
2026
Q1 		$12.4K Hold
1,351
– – ﹤0.01% 2797
2025
Q4 		$21.6K Hold
1,351
– – ﹤0.01% 2606
2025
Q3 		$62.9K Sell
1,351
-466
-26% -$17.1K ﹤0.01% 1971
2025
Q2 		$53.3K Buy
1,817
+586
+48% +$15.9K ﹤0.01% 2148
2025
Q1 		$31.6K Hold
1,231
– – ﹤0.01% 2355
2024
Q4 		$35.5K Hold
1,231
– – ﹤0.01% 2381
2024
Q3 		$29.2K Hold
1,231
– – ﹤0.01% 2470
2024
Q2 		$21.3K Buy
1,231
+900
+272% +$15.7K ﹤0.01% 2584
2024
Q1 		$7.38K Hold
331
– – ﹤0.01% 2890
2023
Q4 		$6.06K Hold
331
– – ﹤0.01% 2941
2023
Q3 		$5.74K Hold
331
– – ﹤0.01% 2967
2023
Q2 		$6.02K Buy
+331
New +$6.61K ﹤0.01% 3001
2022
Q2 		– Sell
-178
Closed -$6K – 3259
2022
Q1 		$6K Hold
178
– – ﹤0.01% 2947
2021
Q4 		$15K Hold
178
– – ﹤0.01% 2770
2021
Q3 		$20K Buy
+178
New +$26.4K ﹤0.01% 2712

Other funds holding LENZ

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Alpha Wave Global
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Ameritas Investment Partners's LENZ Position: Q2 2026 in Review

Ameritas Investment Partners held its LENZ Therapeutics (LENZ) position steady in Q2 2026 at 1,351 shares worth $7.67K. The position accounts for ﹤0.01% of the portfolio, ranked #3050.

Ameritas Investment Partners first reported a position in LENZ in Q3 2021 and has held it in 16 quarters since. The position peaked at $62.9K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Ameritas Investment Partners held 1,351 shares of LENZ Therapeutics worth $7.67K as of Q2 2026.
  • Ameritas Investment Partners left its LENZ Therapeutics share count unchanged in Q2 2026.
  • LENZ Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #3050 holding.
  • Ameritas Investment Partners first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 16 quarters since.
  • Ameritas Investment Partners's LENZ Therapeutics position peaked at $62.9K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.